What is it about?
Erythropoietin Hyporesponsiveness is an interested problem associated with Erythropoietin use especially in patient with CKD that associated with huge healthcare and economic related problems. Melatonin as a medication with anti inflammatory effects can reduce this problems
Featured Image
Photo by kgrkz on Unsplash
Why is it important?
by using a medication with low cost and relatively high safety profile, Erythropoietin Hyporesponsiveness can be reduced, so lowering their associated complications and maintain relatively stable hematological status.
Perspectives
Writing this article was a great pleasure as it has co-authors with whom I have had long standing collaborations. This article also tried to help many physicians who interested with management of CKD to use new approaches to minimize the fatal complications of this disease
Evan Noori Hameed
University of Kufa
Read the Original
This page is a summary of: Melatonin Improves Erythropoietin Hyporesponsiveness via Suppression of Inflammation, Reviews on Recent Clinical Trials, August 2019, Bentham Science Publishers,
DOI: 10.2174/1574887114666190528120357.
You can read the full text:
Contributors
The following have contributed to this page
